Fidelity Investments’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,865,994
| Closed | -$907M | – | 5806 |
|
|
2023
Q4 | $907M | Sell |
2,865,994
-2,784,173
| -49% | -$541M | 0.07% | 249 |
|
|
2023
Q3 | $955M | Buy |
5,650,167
+33,579
| +0.6% | +$6.31M | 0.08% | 212 |
|
|
2023
Q2 | $1.22B | Buy |
5,616,588
+10,502
| +0.2% | +$2.25M | 0.1% | 175 |
|
|
2023
Q1 | $1.02B | Buy |
5,606,086
+453,096
| +9% | +$86.7M | 0.09% | 200 |
|
|
2022
Q4 | $1.01B | Buy |
5,152,990
+701,781
| +16% | +$150M | 0.1% | 194 |
|
|
2022
Q3 | $1B | Sell |
4,451,209
-31,199
| -0.7% | -$6.31M | 0.1% | 171 |
|
|
2022
Q2 | $567M | Sell |
4,482,408
-96,873
| -2% | -$11.1M | 0.06% | 331 |
|
|
2022
Q1 | $581M | Buy |
4,579,281
+5,175
| +0.1% | +$583K | 0.05% | 393 |
|
|
2021
Q4 | $599M | Sell |
4,574,106
-30,000
| -0.7% | -$3.88M | 0.04% | 393 |
|
|
2021
Q3 | $563M | Sell |
4,604,106
-60,000
| -1% | -$6.93M | 0.04% | 394 |
|
|
2021
Q2 | $532M | Hold |
4,664,106
| – | – | 0.04% | 405 |
|
|
2021
Q1 | $561M | Hold |
4,664,106
| – | – | 0.05% | 388 |
|
|
2020
Q4 | $474M | Buy |
4,664,106
+671,720
| +17% | +$62.2M | 0.04% | 423 |
|
|
2020
Q3 | $309M | Buy |
3,992,386
+72,868
| +2% | +$6.21M | 0.03% | 459 |
|
|
2020
Q2 | $437M | Buy |
3,919,518
+7,112
| +0.2% | +$618K | 0.05% | 354 |
|
|
2020
Q1 | $282M | Buy |
3,912,406
+10,493
| +0.3% | +$897K | 0.04% | 400 |
|
|
2019
Q4 | $294M | Buy |
3,901,913
+1,903,322
| +95% | +$83.4M | 0.03% | 500 |
|
|
2019
Q3 | $31.9M | Buy |
1,998,591
+90,800
| +5% | +$1.76M | ﹤0.01% | 1381 |
|
|
2019
Q2 | $36.5M | Buy |
+1,907,791
| New | +$38.2M | ﹤0.01% | 1368 |
|
Other funds holding KRTX
Fidelity Investments's KRTX Position: Q1 2024 in Review
Fidelity Investments sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2,865,994 shares — an estimated $907M sold.
Fidelity Investments first reported a position in KRTX in Q2 2019 and held it in 19 quarters. The position peaked at $1.22B in Q2 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.
- Fidelity Investments reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Fidelity Investments sold 2,865,994 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $907M.
- Fidelity Investments first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2019 and held it in 19 quarters.
- Fidelity Investments's Karuna Therapeutics, Inc. Common Stock position peaked at $1.22B in Q2 2023.
- 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Fidelity Investments's 13F filing for Q1 2024, filed 13 May 2024.